Moomoo AI 已提取核心信息
Bristol-Myers Squibb Company, a leading pharmaceutical company, announced a significant change in its executive team. Effective February 15, 2024, Mr. Phil Holzer has been appointed as the new Senior Vice President and Controller. Mr. Holzer, who has been with the company since 2001, has held various senior roles, most recently serving as Senior Vice President, Finance, Treasury, and Tax Operations from 2021 to 2024. His extensive experience within the company includes positions such as Chief Audit Officer and Vice President, U.S. Commercialization Finance. The outgoing Senior Vice President and Controller, Ms. Sharon Greenlees, will transition to another role within the company on the same date. The announcement confirms that Mr. Holzer has no familial ties with any director or executive officer of the company and is not involved in any transaction that would require disclosure under SEC regulations.
Bristol-Myers Squibb Company, a leading pharmaceutical company, announced a significant change in its executive team. Effective February 15, 2024, Mr. Phil Holzer has been appointed as the new Senior Vice President and Controller. Mr. Holzer, who has been with the company since 2001, has held various senior roles, most recently serving as Senior Vice President, Finance, Treasury, and Tax Operations from 2021 to 2024. His extensive experience within the company includes positions such as Chief Audit Officer and Vice President, U.S. Commercialization Finance. The outgoing Senior Vice President and Controller, Ms. Sharon Greenlees, will transition to another role within the company on the same date. The announcement confirms that Mr. Holzer has no familial ties with any director or executive officer of the company and is not involved in any transaction that would require disclosure under SEC regulations.
领先的制药公司百时美施贵宝公司宣布其执行团队进行重大变动。自2024年2月15日起，菲尔·霍尔泽先生被任命为新的高级副总裁兼财务总监。霍尔泽先生自2001年以来一直在公司工作，曾担任过各种高级职务，最近在2021年至2024年期间担任财务、财政和税务运营高级副总裁。他在公司的丰富经验包括首席审计官和美国商业化融资副总裁等职位。即将离任的高级副总裁兼财务总监莎朗·格林利斯女士将于同日调任公司内部的另一个职位。该公告证实，霍尔泽先生与公司的任何董事或执行官都没有家族关系，也没有参与任何根据美国证券交易委员会法规需要披露的交易。
领先的制药公司百时美施贵宝公司宣布其执行团队进行重大变动。自2024年2月15日起，菲尔·霍尔泽先生被任命为新的高级副总裁兼财务总监。霍尔泽先生自2001年以来一直在公司工作，曾担任过各种高级职务，最近在2021年至2024年期间担任财务、财政和税务运营高级副总裁。他在公司的丰富经验包括首席审计官和美国商业化融资副总裁等职位。即将离任的高级副总裁兼财务总监莎朗·格林利斯女士将于同日调任公司内部的另一个职位。该公告证实，霍尔泽先生与公司的任何董事或执行官都没有家族关系，也没有参与任何根据美国证券交易委员会法规需要披露的交易。
有用
没用
